A detailed history of Sherbrooke Park Advisers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,952 shares of MRK stock, worth $1.29 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
12,952
Previous 9,623 34.59%
Holding current value
$1.29 Million
Previous $1.19 Billion 23.46%
% of portfolio
0.34%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $370,018 - $429,341
3,329 Added 34.59%
12,952 $1.47 Billion
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $1.19 Million - $1.28 Million
9,623 New
9,623 $1.19 Billion
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $338,007 - $367,833
-3,374 Reduced 36.7%
5,819 $634 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $946,419 - $1.05 Million
9,193 New
9,193 $946 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.